Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2003
10/14/2003US6632669 Nucleotide sequences coding enzymatic polypeptide for use amplified fruit propagation
10/14/2003US6632665 Human gene encoding 3′-5′ exonuclease
10/14/2003US6632663 DNA immunization against chlamydia infection
10/14/2003US6632650 Genes involved in cyclododecanone degradation pathway
10/14/2003US6632646 Modified subtilisins and detergent compositions containing same
10/14/2003US6632645 Of given amino acid sequence; use in sequencing, reverse transcription, and amplification reactions
10/14/2003US6632644 Nucleotide sequences which code for the zwa1 gene
10/14/2003US6632643 Generating 1,5 anhydrofructose; obtain 1,4-glucan, incubate with glucan lyase, recover enzyme products
10/14/2003US6632639 Gene encoding RNase E comprises a mutation such that the enzyme produced upon expression does not degrade messsenger RNA; substitution of guanine by thymidine to create a stop codon
10/14/2003US6632638 As a fusion partner; useful for suppressing the competing aggregation pathway and facilitating proper folding; escherichia coli
10/14/2003US6632633 Use of expression cassette, operable in a recombinant host, comprising a heterologous DNA coding sequence encoding a protein which is functional in the conversion of cholesterol into hydrocortisone
10/14/2003US6632631 Identification of antibiotics, preferably antifungals that affect the biosynthesis of lysine
10/14/2003US6632627 DNA coding for the protein; useful for a prophylactic or therapeutic agent for hypoglycemia.
10/14/2003US6632626 Cancer; anticarcinogenic agents; use of purified enzyme in screening protocols for the identification of possible anti-cancer agents which inhibit the enzyme and thereby prevent expression of the oncogenic ras proteins such as p21ras
10/14/2003US6632614 Method for detecting anti-Streptococcus pyogenes DNase B antibody in a test sample
10/14/2003US6632602 Transgenic plants; use to alter levels of hexokinase protein expression in plants in order to repress/activate plant genes controlling physiology, metabolism, and cell development with emphasis on improved yields and quality of agricultural crops
10/14/2003US6632600 Altered thermostability of enzymes
10/14/2003US6632028 Apparatus and method for aligning an optical fiber with an optical device
10/14/2003CA2290776C Proteins having insecticidal activities and method of use
10/14/2003CA2215167C Reagent stabilized using coenzyme reduction system
10/14/2003CA2167521C Compositions and methods for producing sialyltransferases
10/14/2003CA2114104C Nucleotide sequences of galactinol synthase from zucchini and soybean
10/14/2003CA2107894C Crosstalk inhibitors and their uses
10/09/2003WO2003083125A1 Ehanced protein expression in bacillus
10/09/2003WO2003083123A2 Improved method for the production of vitamin b12
10/09/2003WO2003083119A1 Transgenic plant expressing phosphoenolpyruvate carboxykinase
10/09/2003WO2003083118A1 Genes encoding acetolactate synthase
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083110A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/09/2003WO2003083109A1 Selection marker gene
10/09/2003WO2003083104A1 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made thereform
10/09/2003WO2003083102A2 Cancer associated protein phosphatases and their uses
10/09/2003WO2003083101A1 Dap kinase crystals, method of screening candidate for drug targeting dap kinase using the same and drug obtained thereby
10/09/2003WO2003083100A1 Expression of phospholipid:diacylglycerine acyltransferase (pdat) for the production of plant storage lipids with polyunsaturated fatty acids
10/09/2003WO2003083099A2 Purified polypeptides involved in protein synthesis and modification
10/09/2003WO2003083098A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/09/2003WO2003083097A1 Pleckstrin homology domain structure
10/09/2003WO2003083096A2 Cancer associated protein kinases and their uses
10/09/2003WO2003083094A1 Hbv drug resistance drug resistance detection methods
10/09/2003WO2003083086A2 High level expression of immunogenic proteins in the plastids of higher plants
10/09/2003WO2003083084A2 Protein modification and maintenance molecules
10/09/2003WO2003083082A2 Enzymes
10/09/2003WO2003083081A2 Lipid-associated molecules
10/09/2003WO2003083060A2 Crystals and structures of mst3
10/09/2003WO2003083054A2 Amylases, nucleic acids encoding them and methods for making and using them
10/09/2003WO2003083052A2 Method of using anti-apoptotic factors in gene expression
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083045A2 Lambda integrase mediated recombination in plants
10/09/2003WO2003083043A2 Methods for producing secreted polypeptides having l-asparaginase activity
10/09/2003WO2003083038A2 Disruption of the redk gene
10/09/2003WO2003082914A1 Prothrombin activating protein
10/09/2003WO2003082911A2 Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics
10/09/2003WO2003082909A1 Non-ribosomal peptide synthetases and associated biosynthetic genes
10/09/2003WO2003082899A2 Compositions and methods for altering tocotrienol content
10/09/2003WO2003082324A1 Prevention and treatment of mycoplasma-associated diseases
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082187A2 Purification and cloning of nmn adenylyltranserase and its therapeutic use
10/09/2003WO2003082184A2 Truncated lysostaphin molecule with enhanced staphylolytic activity
10/09/2003WO2003081997A1 CALPAIN LARGE SUBUNIT (n-CL4) CYSTEINE PROTEASE GENE DISRUPTIONS, AND COMPOSITIONS AND METHODS RELATED THERETO
10/09/2003WO2003050896A3 Biocompatible membranes and fuel cells produced therewith
10/09/2003WO2003035856A3 Protein with kinase activity
10/09/2003WO2003018787A3 Purified human hscas1 gene, polypeptides encoded by hscas1 for o-acetylation of sialic acids and for the diagnosis and prognosis of cancer
10/09/2003WO2003012133A3 Isp-1 and ctb-1 genes and uses thereof
10/09/2003WO2003012131A3 Assays for protease inhibitors, methods and means
10/09/2003WO2003012116A3 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003000884A3 Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002083936A3 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/09/2003WO2002079505A3 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci
10/09/2003WO2002072786A3 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002031160A3 Regulation of human phospholipase a2-like enzyme
10/09/2003US20030192072 Isolation of a glyphosate herbicide resistant EPSP synthase ( 5-enolpyruvylshikimate-3-phosphte synthase) coding sequence and its regulatory elements from Eleusine indica
10/09/2003US20030192071 Isolated and purified nucleic acids comprising a gene and a regulatory region for the gene expression of the same
10/09/2003US20030192069 Glycerol kinase gene disruptions, compositions and methods related thereto
10/09/2003US20030192068 Production of recombinant polypeptides by bovine species and transgenic methods
10/09/2003US20030191299 PRO polypeptides fused to heterologous polypeptide sequences
10/09/2003US20030191292 Of viruses from solution containing macromolecules; increased salt content; reduces residence time
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191083 Screening, detection microbiocides; sepsis, rheumatic diseases, antiarthritic agents; bactericides
10/09/2003US20030191073 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
10/09/2003US20030191060 Respiratory system disorders; cardiovascular disorders; controlling signal transduction
10/09/2003US20030191059 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders
10/09/2003US20030191039 Modified subtilisins and detergent, compositions containing same
10/09/2003US20030191038 Subtilase enzymes
10/09/2003US20030190741 Useful as an additive for feeds and in the decomposition of hemicellulose
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190738 For use in starch conversion process comprising liquefaction, saccharification; improved thermostability
10/09/2003US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
1 ... 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 ... 1416